UBS Group’s Imperva, Inc. IMPV Stock Holding History

UBS Group’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-18,800	Closed	-$1.01M	–	8240
2016 Q3	$1.01M	Buy	+18,800	New	+$873K	﹤0.01%	3419
2015 Q1	–	Sell	-400	Closed	-$20K	–	9722
2014 Q4	$20K	Buy	+400	New	+$16K	﹤0.01%	7699

UBS Group's IMPV Position: Q1 2019 in Review

UBS Group sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 638,020 shares — an estimated $35.5M sold.

UBS Group first reported a position in IMPV in Q4 2014 and held it in 17 quarters. The position peaked at $35.5M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

UBS Group reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
UBS Group sold 638,020 Imperva, Inc. shares in Q1 2019, an estimated $35.5M.
UBS Group first reported a position in Imperva, Inc. in Q4 2014 and held it in 17 quarters.
UBS Group's Imperva, Inc. position peaked at $35.5M in Q4 2018.
0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.